These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Microscopic haematuria in patients with rheumatoid arthritis on d-penicillamine. Barraclough D; Cunningham TJ; Muirden KD Aust N Z J Med; 1981 Dec; 11(6):706-8. PubMed ID: 6949548 [No Abstract] [Full Text] [Related]
9. [The basal therapy of rheumatoid arthritis with d-penicillamine (author's transl)]. Waskönig FW; Meyer W Munch Med Wochenschr; 1973 Nov; 115(45):2047-50. PubMed ID: 4801138 [No Abstract] [Full Text] [Related]
10. Renal changes in patients with rheumatoid arthritis treated with sodium thiomalate and D-penicillamine. Domljan Z; Borso G; Marinković M; Winter Fudurić I; Pucar I; Cikes N Acta Med Iugosl; 1987; 41(5):363-72. PubMed ID: 3128058 [No Abstract] [Full Text] [Related]
11. Management of proteinuria secondary to penicillamine therapy in rheumatoid arthritis. DeSilva RN; Eastmond CJ Clin Rheumatol; 1992 Jun; 11(2):216-9. PubMed ID: 1617896 [TBL] [Abstract][Full Text] [Related]
12. Longterm followup of treatment with D-penicillamine for rheumatoid arthritis: effectivity and toxicity in relation to HLA antigens. Moens HJ; Ament BJ; Feltkamp BW; van der Korst JK J Rheumatol; 1987 Dec; 14(6):1115-9. PubMed ID: 3437418 [TBL] [Abstract][Full Text] [Related]
13. The relationship between D-penicillamine--induced proteinuria and prior gold nephropathy. Billingsley LM; Stevens MB Johns Hopkins Med J; 1981 Feb; 148(2):64-7. PubMed ID: 7206401 [TBL] [Abstract][Full Text] [Related]
14. [Undesirable effects of D-penicillamine in the therapy of rheumatoid arthritis]. Trnavský K; Zbojanová M Fysiatr Revmatol Vestn; 1979 Apr; 57(2):87-91. PubMed ID: 570949 [No Abstract] [Full Text] [Related]
15. Penicillamine nephropathy in rheumatoid arthritis. A clinical, pathological and immunological study. Bacon PA; Tribe CR; Mackenzie JC; Verrier-Jones J; Cumming RH; Amer B Q J Med; 1976 Oct; 45(180):661-84. PubMed ID: 1005658 [TBL] [Abstract][Full Text] [Related]
16. [Clinical experiences with d-penicillamine in rheumatoid arthritis (author's transl)]. Saxer M; Oeding A; Kaganas G; Vogt E Schweiz Rundsch Med Prax; 1977 Feb; 66(8):240-6. PubMed ID: 840828 [No Abstract] [Full Text] [Related]
17. Penicillamine treatment of rheumatoid arthritis: relationship of proteinuria and autoantibodies to immune status. Zilko PJ; Dawkins RL; Cohen ML Proc R Soc Med; 1977; 70 Suppl 3(Suppl 3):118-22. PubMed ID: 122657 [TBL] [Abstract][Full Text] [Related]
18. [D-penicillamine (Artamin) as basic therapeutic agent in the treatment of chronic rheumatoid arthritis]. Tausch G; Bröll H; Eberl R Wien Klin Wochenschr; 1973 Jan; 85(4):59-63. PubMed ID: 4567434 [No Abstract] [Full Text] [Related]
19. HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis. Wooley PH; Griffin J; Panayi GS; Batchelor JR; Welsh KI; Gibson TJ N Engl J Med; 1980 Aug; 303(6):300-2. PubMed ID: 6770269 [TBL] [Abstract][Full Text] [Related]
20. Should one use second-line agents such as gold and D-penicillamine in a patient with active rheumatoid arthritis and asymptomatic microscopic haematuria for which no cause can be determined? Bird HA Br J Rheumatol; 1989 Feb; 28(1):39. PubMed ID: 2492869 [No Abstract] [Full Text] [Related] [Next] [New Search]